Care quality is high in both the United States and Canada, but there are commonalities in regard to drug access and cost issues, particularly with advanced medications, noted G. B. John Mancini, MD, University of British Columbia.
Care quality is high in both the United States and Canada, but there are commonalities in regard to drug access and cost issues, particularly with advanced medications, noted G. B. John Mancini, MD, professor of medicine; scientific director, Cardio Risk Clinic; and director of the Cardiovascular Imaging Research Core Laboratory, University of British Columbia.
Transcript
What are key differences in the accessibility, cost, and quality of cardiac care between the United States and Canada?
I think the quality of care is really very high in North America, both in Canada and in United States. Of course, the Canadian system has so-called universal health care where basic care is provided by the government. On the other hand, we don't have a national drug plan, and even so-called Medicare drug coverage in the US is more universal than in Canada—it's quite province specific in Canada. So those are a few differences.
The access to drugs is affected similarly, as in the US, with regards to the actual costs. And because most of those costs are paid by insurance companies, if a patient has insurance, usually through employment, then it becomes a big issue of access. And of course, out-of-pocket expenses can accumulate if patients don't have drug coverages. So some of the differences really wash out in the laundry, so to speak. There's a lot of commonality in terms of drug access and cost issues, particularly with advanced medications.
How do insurance coverage and reimbursement systems differ between the United States and Canada?
As best I am aware, in terms of gross domestic product, we don't spend as much as in the US, for example, but the outcomes are still relatively comparable. And so where we have a big difference is that each province has sort of a single-payer system, where it's the Ministry of Health that negotiates physician fees and then pays them as care is delivered. I don't believe that there's huge differences in that regard that affect quality. We do have currently, in Canada, a bit of a crisis in terms of primary care, where a lot of citizens don't have access to a primary care physician who would initiate access to specialists and so on. So that is perhaps one difference that is currently at play.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
How Pharmacy Deserts, Biosimilars, and Market Trends Are Shaping Managed Care
April 2nd 2025Rising biosimilar adoption, shifting market dynamics, and escalating supply chain vulnerabilities are driving change in managed care, creating both challenges and opportunities for stakeholders, as explored by speakers at the Academy of Managed Care Pharmacy’s annual meeting.
Read More
Robert F. Kennedy Jr Faces Senate Inquiry Over Deep Cuts to HHS Impacting FDA, CDC, NIH, CMS
April 2nd 2025A bipartisan letter from lawmakers questions the legality of Robert F. Kennedy Jr's HHS changes and the lack of clear communication regarding their potential impact on American health.
Read More